Satsuma Pharmaceuticals Stock Forecast - Naive Prediction
| STSADelisted Stock | USD 1.10 0.01 0.90% |
The Naive Prediction forecasted value of Satsuma Pharmaceuticals on the next trading day is expected to be 1.21 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.03. Satsuma Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Satsuma Pharmaceuticals stock prices and determine the direction of Satsuma Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Satsuma Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Satsuma |
Satsuma Pharmaceuticals Naive Prediction Price Forecast For the 1st of February
Given 90 days horizon, the Naive Prediction forecasted value of Satsuma Pharmaceuticals on the next trading day is expected to be 1.21 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.03.Please note that although there have been many attempts to predict Satsuma Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Satsuma Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Satsuma Pharmaceuticals Stock Forecast Pattern
| Backtest Satsuma Pharmaceuticals | Satsuma Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Satsuma Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Satsuma Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.651 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0497 |
| MAPE | Mean absolute percentage error | 0.0563 |
| SAE | Sum of the absolute errors | 3.0292 |
Predictive Modules for Satsuma Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Satsuma Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Satsuma Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
View Satsuma Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Satsuma Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Satsuma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Satsuma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Satsuma Pharmaceuticals stock market strength indicators, traders can identify Satsuma Pharmaceuticals entry and exit signals to maximize returns.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |